MFSD6L is a 586-amino acid transmembrane protein belonging to the Major Facilitator Superfamily (MFS), which facilitates small solute transport via chemiosmotic gradients . Key features include:
Molecular Weight: 64 kDa (precursor), increasing to 72 kDa post-glycosylation .
Structure: 11 transmembrane domains and two MFS-specific regions (residues 28–368) .
Expression: Highly expressed in glandular tissues (pancreas, thyroid) and upregulated under glucose starvation .
Function: Predicted role in antigen processing via MHC class I interactions, with potential disease links to viral encephalitis .
Anti-MFSD6L antibodies are produced by multiple suppliers, with variations in applications, reactivity, and formats.
MFSD6L antibodies are utilized in diverse experimental workflows:
Subcellular Localization: Confirmed membrane localization via WB and immunofluorescence .
Post-Translational Modifications: Detected glycosylation at residues N110, N129, and N224 using glycosidase-treated lysates .
Disease Association: Elevated MFSD6L expression observed in glucose-starved cancer cells, suggesting metabolic adaptation roles .
Proteintech’s antibody (27730-1-AP) exemplifies rigorous validation:
Specificity: Recognizes a single band at 64 kDa in human cell lines .
Cross-Reactivity: No reactivity with mouse or rat orthologs .